- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02015182
Bupivacaine Pharmacokinetics Following TAP Block
Bupivacaine Pharmacokinetics in Children Following Transversus Abdominis Plane Block
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X8
- The Hospital for Sick Children
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients receiving a TAP block as part of routine anesthetic management
- Patients older than 3 months and less than 18 years of age
- Patients weighing ≥ 6 kg
- Patients with American Society of Anesthesiologists (ASA) score 1-3
Exclusion Criteria:
- Patients with known severe preexisting liver disease
- Patients with known severe (i.e. requiring dialysis) preexisting renal disease
- Patients who will be discharged the day of surgery
- Refusal to consent
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Blood sample for bupivicaine pharmacokinetics
Children undergoing TAP block will have blood sampled for bupivacaine pharmacokinetics
|
Bupivacaine levels will be measured with an assay developed on the 4000 QTrap Tandem Mass Spectrometer (Applied Biosystems/ MDS Sciex). Data will be collected and analyzed using the Agilent ChemStation software (Rev A.10.02). The analytical column is an Agilent Zorbax Eclipse XDB-C8 (4.6 x 150mm, 5µm).Quantification of bupivacaine is based on analyzing a six point calibration curve (0 to 4.0 mg/L). An internal standard (Prilocaine 221.2/86.1) is included with each calibrator, quality control or patient sample. Instrumentation and Chromatographic conditions: The HPLC system consists of a Specta-System P1000 Isocratic Pump and an AS3000 Autosampler (Thermo Electron Corporation, Waltham MA). |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Population pharmacokinetics of bupivacaine and the influence of patient covariates on drug disposition
Time Frame: 0 - 360 minutes after the TAP block is performed
|
Blood will be drawn from an indwelling intravenous catheter.
Each patient will have a total of 6 samples collected during each of the following time blocks: 0 - 10 minutes, 11 - 20 minutes, 21 - 30 minutes, 31 - 60 minutes, 61 - 180 minutes and 181 - 360 minutes after the TAP block is performed.
Age, weight, sex, concomitant drugs (intravenous and inhalation anesthetics, muscle relaxants, and opioids), and kidney function data will be investigated as co-variables for each of the primary parameters.
We will obtain estimates of total clearance (CL), volume of distribution, elimination half life (t1/2), estimates of clearance, and absorption rate constant.
|
0 - 360 minutes after the TAP block is performed
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jason Hayes, The Hospital for Sick Children
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1000023222
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Transversus Abdominis Plane Block
-
Yuzuncu Yıl UniversityCompletedTransversus Abdominis Plane BlockTurkey
-
Assiut UniversityCompleted
-
Herlev HospitalGlostrup University Hospital, CopenhagenCompleted
-
Damanhour Teaching HospitalCompletedTransversus Abdominis Plane (TAP) BlockEgypt
-
Pontificia Universidad Catolica de ChileCompletedTransversus Abdominis Plane BlockChile
-
The General Authority for Teaching Hospitals and...CompletedCesarean Section | Quadratus Lumborum Block | Transversus Abdominis Plane BlockEgypt
-
United Christian HospitalUnknownTransversus Abdominis Plane Block From Abdominal ApproachHong Kong
-
University Hospital, BordeauxCompletedAbdominoplasty | Transversus Abdominis Plane (TAP) BlockFrance
-
University Tunis El ManarCompletedCesarean Section | Anesthesia | Adverse Effect | Transversus Abdominis Plane Block
-
Chinese PLA General HospitalUnknownLearning Curve | Simulation Training | Transversus Abdominis Plane BlockChina
Clinical Trials on Blood sample for bupivicaine pharmacokinetics
-
Centre Hospitalier Universitaire de Saint EtienneNot yet recruitingKidney Function TestFrance
-
Centre Henri BecquerelUniversitaire Ziekenhuizen KU Leuven; Erasmus Medical CenterNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, FranceActive, not recruiting
-
University Hospital Center of MartiniqueInstitut Pasteur de Guadeloupe; Centre de Ressources Biologiques de la Martinique...Not yet recruitingSystemic Lupus Erythematosus | Renal DiseaseFrance
-
Lund UniversityThe Swedish Research CouncilRecruiting
-
University Hospital, Clermont-FerrandHeart and Research Foundation; French Coronary Atheroma and Interventional...CompletedSpontaneous Coronary Artery Dissection | Spontaneous Coronary Artery HaematomaFrance
-
University Hospital, Strasbourg, FranceGroupement Interrégional de Recherche Clinique et d'Innovation EstRecruitingApparent Life-Threatening Event in Infants Under One Year of AgeFrance
-
University Hospital, Strasbourg, FranceCompletedSARS-CoV-2 Serological Status | SARS-CoV-2 SeroprevalenceFrance
-
University Hospital, MontpellierInstitut National de la Santé Et de la Recherche Médicale, France; Sys2Diag...Completed